Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection.

Chen, Yinbo; Li, Cong; Du, Yian; Xu, Qi; Ying, Jieer; Luo, Cong

Chen, Yinbo; Li, Cong; Du, Yian; Xu, Qi; Ying, Jieer; Luo, Cong.

Afiliação

Chen Y; Department of Colorectal Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Li C; Department of Lymphoma Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Du Y; Department of Abdominal Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Xu Q; Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Ying J; Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Luo C; Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.

Oncotarget ; 8(41): 70841-70846, 2017 Sep 19.

Article em En | MEDLINE | ID: mdl-29050324

Palavras-chave

adjuvant chemotherapy; gastric cancer; lymph node ratio

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google